BIO Professional Development
Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth
Recorded Understanding Commercialization Within Biopharma Master Course
This is the recorded Understanding Commercialization Within Biopharma course with the same content, interactive exercises, and course materials that are given in the live version. You have 3 months to view this course.
Understanding Commercialization Within Biopharma is an eight-hour course that uses real-world examples to explain the big picture of strategic commercialization and the tactics necessary for a successful pharmaceutical launch. Discussion points focus on creating the Therapeutic Target Profile (TPP), the power of market segmentation, crafting the value story, and building/sustaining competitive advantage. This course is for scientists and non-scientists who need to understand how therapeutics are successfully launched and commercialized.
BIO members receive a $100 discount. BIO members should use the code BIOTRAINING2022 to register for this course.
Takeaways
- Identify key commercialization success factors and their value as a core, differentiating competency.
- Gain access to a commercialization “toolbox” that can be immediately and practically applied.
- Internalize a deep understanding of the product launch process.
- Recognize key issues, opportunities, and challenges of effective commercialization strategy and tactics.
- Discover tools needed to build compelling and effective value-demonstration stories that help optimize reimbursement and market access.
Certificate Requirements
- View entire course
- Read all articles
- Answer all knowledge check questions
Experienced dealmakers will prove a deep dive on early capitalization from investors (not grants).
Learn about the science driving today’s hottest biopharma innovations including CRISPR, CAR-T, gene therapy, and much more...
Gain a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world...
.png){kind=logo}
